Blog

Secures up to $60 million in financing from Midcap Financial Toronto, Ontario – January 10, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced preliminary financial results for fourth quarter and full year 2016 … Continue reading “NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue and Issues 2017 Revenue guidance”

Toronto, Ontario – January 4, 2017 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Lisa Colleran has been appointed to its board of directors, effective immediately. Lisa Colleran is a veteran in … Continue reading “NOVADAQ appoints Lisa Colleran to its board of directors”

The PINPOINT Endoscopic Fluorescence Imaging System was recently featured in the AIS Channel’s live streaming international consensus on rectal cancer surgery. The London-based event was broadcast to showcase and discuss the four common surgical strategies for rectal cancer. World renowned experts presented during the event and four live rectal cancer surgeries were performed simultaneously in … Continue reading “PINPOINT Utilized During International Symposium on the Future of Rectal Cancer Surgery”

NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, will present on the Company’s business at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, … Continue reading “NOVADAQ to Present at the 35th Annual J.P. Morgan Healthcare Conference”

Patients reconstructed with DermACELL as compared to AlloDerm RTU have significantly decreased number of days to drain removal and ‘red breast’ syndrome. Rates of other complications including seroma, infection, flap necrosis and explantation were equivalent. An article recently accepted and made available online by Plastic and Reconstructive Surgery compared the clinical outcomes between two acellular … Continue reading “Comparison of Different Acellular Dermal Matrix (ADM) in Breast Reconstruction: The 50/50 Study”

NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, is scheduled for a fireside presentation at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, November 29th … Continue reading “NOVADAQ to Present at the 28th Annual Piper Jaffray Healthcare Conference”

Toronto, Ontario – November 8, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technologies and … Continue reading “NOVADAQ to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum”

NOVADAQ Reports Third Quarter 2016 Financial Results  Toronto, Ontario – November 2, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third quarter ended September 30, 2016. Unless otherwise … Continue reading “NOVADAQ Reports Third Quarter 2016 Financial Results”

TORONTO, Oct. 20, 2016 (GLOBE NEWSWIRE) — NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2016 after market close on Wednesday, November 2, 2016. NOVADAQ President and … Continue reading “NOVADAQ to Release Third Quarter 2016 Financial Results on November 2, 2016—Conference Call to Follow”

Toronto, Ontario – September 6, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Karen A. Licitra will be joining the Company’s Board of Directors. Ms. Licitra has a track record of accomplishments in sales, … Continue reading “NOVADAQ Announces Appointment of Karen A. Licitra to its Board of Directors”